Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #7,101 to #7,150.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Meprobamate (patient information) (1 revision)
  2. Mercaptopurine (patient information) (1 revision)
  3. Merck Sharp & Dohme (1 revision)
  4. Mercurial diuretic (1 revision)
  5. Mercury(II) iodide (1 revision)
  6. Mercury(II) oxide (1 revision)
  7. Mercury poisoning (1 revision)
  8. Mercy Health Partners (1 revision)
  9. Mercy Hospital of Defiance (1 revision)
  10. Mercy Hospital of Tiffin (1 revision)
  11. Mercy Hospital of Willard (1 revision)
  12. Merocrine (1 revision)
  13. Meromelia (1 revision)
  14. Meropenem Injection (patient information) (1 revision)
  15. Mesalamine (patient information) (1 revision)
  16. Mesangial proliferative glomerulonephritis CT (1 revision)
  17. Mesangial proliferative glomerulonephritis MRI (1 revision)
  18. Mesangial proliferative glomerulonephritis case study one (1 revision)
  19. Mesangial proliferative glomerulonephritis causes (1 revision)
  20. Mesangial proliferative glomerulonephritis chest x ray (1 revision)
  21. Mesangial proliferative glomerulonephritis classification (1 revision)
  22. Mesangial proliferative glomerulonephritis cost-effectiveness of therapy (1 revision)
  23. Mesangial proliferative glomerulonephritis differential diagnosis (1 revision)
  24. Mesangial proliferative glomerulonephritis echocardiography or ultrasound (1 revision)
  25. Mesangial proliferative glomerulonephritis electrocardiogram (1 revision)
  26. Mesangial proliferative glomerulonephritis epidemiology and demographics (1 revision)
  27. Mesangial proliferative glomerulonephritis future or investigational therapies (1 revision)
  28. Mesangial proliferative glomerulonephritis historical perspective (1 revision)
  29. Mesangial proliferative glomerulonephritis history and symptoms (1 revision)
  30. Mesangial proliferative glomerulonephritis laboratory findings (1 revision)
  31. Mesangial proliferative glomerulonephritis medical therapy (1 revision)
  32. Mesangial proliferative glomerulonephritis natural history, complications and prognosis (1 revision)
  33. Mesangial proliferative glomerulonephritis other diagnostic studies (1 revision)
  34. Mesangial proliferative glomerulonephritis other imaging findings (1 revision)
  35. Mesangial proliferative glomerulonephritis pathophysiology (1 revision)
  36. Mesangial proliferative glomerulonephritis physical examination (1 revision)
  37. Mesangial proliferative glomerulonephritis risk factors (1 revision)
  38. Mesangial proliferative glomerulonephritis screening (1 revision)
  39. Mesangial proliferative glomerulonephritis secondary prevention (1 revision)
  40. Mesangial proliferative glomerulonephritis ultrasound (1 revision)
  41. Mescaline (1 revision)
  42. Mesencephalon (1 revision)
  43. Mesenteric glands (1 revision)
  44. Mesenteric ischemia case study one (1 revision)
  45. Mesenteric ischemia cost-effectiveness of therapy (1 revision)
  46. Mesenteric ischemia future or investigational therapies (1 revision)
  47. Mesentery (1 revision)
  48. Mesh (1 revision)
  49. Mesna (patient information) (1 revision)
  50. Mesoblastic nephroma case study one (1 revision)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:FewestRevisions"